Search

Your search keyword '"Jere, Haswel"' showing total 9 results
Start Over Author "Jere, Haswel"
9 results on '"Jere, Haswel"'

5. CMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding

Author

Pirillo, Maria Franca, primary, Liotta, Giuseppe, additional, Andreotti, Mauro, additional, Jere, Haswel, additional, Sagno, Jean-Baptiste, additional, Scarcella, Paola, additional, Mancinelli, Sandro, additional, Buonomo, Ersilia, additional, Amici, Roberta, additional, Marazzi, Maria Cristina, additional, Vella, Stefano, additional, Palombi, Leonardo, additional, and Giuliano, Marina, additional

Published
2016
Full Text
View/download PDF

6. Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi

Author

Mancinelli, Sandro, primary, Galluzzo, Clementina Maria, additional, Andreotti, Mauro, additional, Liotta, Giuseppe, additional, Jere, Haswel, additional, Sagno, Jean-Baptiste, additional, Amici, Roberta, additional, Pirillo, Maria Franca, additional, Scarcella, Paola, additional, Marazzi, Maria Cristina, additional, Vella, Stefano, additional, Palombi, Leonardo, additional, and Giuliano, Marina, additional

Published
2016
Full Text
View/download PDF

7. Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi

Author

Palombi, Leonardo, primary, Galluzzo, Clementina Maria, additional, Andreotti, Mauro, additional, Liotta, Giuseppe, additional, Jere, Haswel, additional, Sagno, Jean-Baptiste, additional, Luhanga, Richard, additional, Mancinelli, Sandro, additional, Amici, Roberta, additional, Marazzi, Maria Cristina, additional, Vella, Stefano, additional, and Giuliano, Marina, additional

Published
2015
Full Text
View/download PDF

8. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi

Author

Giuliano, Marina, primary, Liotta, Giuseppe, additional, Andreotti, Mauro, additional, Mancinelli, Sandro, additional, Buonomo, Ersilia, additional, Scarcella, Paola, additional, Amici, Roberta, additional, Jere, Haswel, additional, Sagno, Jean-Baptiste, additional, Di Gregorio, Massimiliano, additional, Marazzi, Maria Cristina, additional, Vella, Stefano, additional, and Palombi, Leonardo, additional

Published
2015
Full Text
View/download PDF

9. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.

Author

Giuliano, Marina, Liotta, Giuseppe, Andreotti, Mauro, Mancinelli, Sandro, Buonomo, Ersilia, Scarcella, Paola, Amici, Roberta, Jere, Haswel, Sagno, Jean-Baptiste, Di Gregorio, Massimiliano, Marazzi, Maria Cristina, Vella, Stefano, and Palombi, Leonardo

Subjects
HIV-positive women, CD4 lymphocyte count, ANTIRETROVIRAL agents, FOLLOW-up studies (Medicine), HIV prevention, VERTICAL transmission (Communicable diseases), COMMUNICABLE diseases, DRUGS, HIV infections, HOSPITAL admission & discharge, LONGITUDINAL method, PATIENT compliance, PREGNANCY complications, PREGNANCY & psychology, PUERPERIUM, VIRAL load, HIGHLY active antiretroviral therapy, TREATMENT effectiveness, HUMAN research subjects, PROPORTIONAL hazards models, ANTI-HIV agents, PATIENTS' attitudes, PREVENTION
Abstract

In this study, we analysed in a cohort of pregnant women followed for two years the proportion of women remaining at the same clinic, those who transferred to other clinics, and those lost to follow-up. The possible determinants of the loss to follow-up were also assessed in a setting of postpartum discontinuation based on CD4+ count. A total of 311 pregnant women received antiretroviral therapy from week 25 of gestational age until six months postpartum (end of breastfeeding period), or indefinitely if meeting the criteria for treatment (baseline CD4+ <350 cells/mm(3)). Twenty-four months after delivery, six women had died, 247 were in active follow-up, 21 had transferred to another antiretroviral therapy clinic and 37 were lost to follow-up (rate of loss to follow-up 13%, 95% CI 9.1-16.9%). The presence of a baseline CD4+ count above 350 cells/mm(3) was associated with a ten-fold higher risk of loss to follow-up after six months of delivery (hazard ratio: 9.8, 95% CI 2.2-42.7, for baseline CD4 >350 cells/mm(3) versus baseline CD4+ count below 350 cells/mm(3), p = 0.002). This finding suggests that discontinuation of drugs when the risk of transmission has ceased can have a negative impact on the retention in care of these women. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results